M. Jädersten: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Cost Effectiveness of Lenalidomide in the Treatment of Transfusion-Dependent Myelodysplastic Syndromes in the United States

Goss, Thomas F., Szende, Agota, Schaefer, Caroline, Totten, P. Jane, Knight, Robert, Jädersten, Martin, Hellström-Lindberg, Eva, List, Alan F.

Journal:

Year:

2006

Language:

english

File:

PDF, 430 KB

english, 2006

2

Biphasic effect of transforming growth factor-beta on Epstein-Barr virus-induced activation of human tonsillar B cells

Aysin Altiok, Martin Jädersten, Tamas Magyarlaki, Eva Klein

Journal:

Immunology Letters

Year:

1994

Language:

english

File:

PDF, 411 KB

english, 1994

3

O-17 Thalidomide analogue CC5013 (revlimid) selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5Q deletion

M. Jadersten, A.-M. Forsblom, E.K. Emanuelsson, M. Merup, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

4

C023 Expression profiling of CD34+ cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes

A. Pellagatti, M. Cazzola, A. Giagounidis, L. Malcovati, M.G. Della Porta, M. Jädersten, S. Killick, C. Fidler, H. Cattan, D. Bowen, C. Aul, E. Hellström-Lindberg, J.S. Wainscoat, J. Boultwood

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 52 KB

english, 2007

5

P136 Treatment with erythropoietin and G-CSF improves survival in MDS patients with low transfusion need

M. Jädersten, L. Malcovati, I. Dybedal, M.G. Della Porta, R. Invernizzi, S.M. Montgomery, C. Pascutto, A. Porwit-MacDonald, M. Cazzola, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 166 KB

english, 2007

6

C014 Expression of p53 or cytoplasmic nucleophosmine associated with increased risk of disease progression in myelodysplastic syndrome with isolated del(5q)

M. Jadersten, L. Saft, H. Garelius, R. Hast, L. Nilsson, J. Samuelsson, A. Porwit, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 65 KB

english, 2009

7

C028 Lenalidomide abrogates the clonal advantage of del(5q) MDS stem cells via alteration of niche interactions

C. Scharenberg, M. Jadersten, J. Palmquist, L. Forsblom, M. Jansson, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 46 KB

english, 2009

8

18 Prognostic impact of TP53 mutations in MDS with del(5q)

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 50 KB

english, 2011

9

19 Debate: Lenalidomide is the standard of care for the management of isolated del 5(q) MDS

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 64 KB

english, 2011

10

259 The clonal advantage of del(5q) MDS stem cells is mediated by increased adhesion to the microenvironment

C. Scharenberg, V. Giai, M. Jädersten, L. Forsblom, M. Jansson, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 76 KB

english, 2011

11

Gene expression profiling of CD34+ cells in patients with the 5q− syndrome

Jacqueline Boultwood, Andrea Pellagatti, Helen Cattan, Charles H. Lawrie, Aristoteles Giagounidis, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Carrie Fidler, Mario Cazzola,

Journal:

British Journal of Haematology

Year:

2007

Language:

english

File:

PDF, 521 KB

english, 2007

12

Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes

Andrea Pellagatti, Eva Hellström-Lindberg, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Carrie Fidler, Mario Cazzola, James S. Wainscoa

Journal:

British Journal of Haematology

Year:

2008

Language:

english

File:

PDF, 360 KB

english, 2008

13

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes

Andrea Pellagatti, Teresa Marafioti, Jennifer C. Paterson, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Beena Pushkaran, Tracy I. George, Daniel A. Arber, Sally Killick, Aristoteles Giagou

Journal:

British Journal of Haematology

Year:

2009

Language:

english

File:

PDF, 242 KB

english, 2009

14

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome

Andrea Pellagatti, Mario Cazzola, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Paresh Vyas, Eva Hellström-Lindberg, James S. Wainscoat,

Journal:

British Journal of Haematology

Year:

2011

Language:

english

File:

PDF, 77 KB

english, 2011

15

Myelodysplastic syndromes: biology and treatment

M. Jädersten, E. Hellström-Lindberg

Journal:

Journal of Internal Medicine

Year:

2009

Language:

english

File:

PDF, 368 KB

english, 2009

16

Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome

Carlsten, M, Baumann, B C, Simonsson, M, Jädersten, M, Forsblom, A-M, Hammarstedt, C, Bryceson, Y T, Ljunggren, H-G, Hellström-Lindberg, E, Malmberg, K-J

Journal:

Year:

2010

Language:

english

File:

PDF, 733 KB

english, 2010

17

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells

Pellagatti, A, Cazzola, M, Giagounidis, A, Perry, J, Malcovati, L, Della Porta, M G, Jädersten, M, Killick, S, Verma, A, Norbury, C J

Journal:

Year:

2010

Language:

english

File:

PDF, 521 KB

english, 2010

18

New clues to the molecular pathogenesis of myelodysplastic syndromes

Martin Jädersten, Eva Hellström-Lindberg

Journal:

Experimental Cell Research

Year:

2010

Language:

english

File:

PDF, 576 KB

english, 2010

19

Identification of Gene Expression-Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes

Pellagatti, A., Benner, A., Mills, K. I., Cazzola, M., Giagounidis, A., Perry, J., Malcovati, L., Della Porta, M. G., Jadersten, M., Verma, A., McDonald, E.-J., Killick, S., Hellstrom-Lindberg, E., Bu

Journal:

Journal of Clinical Oncology

Year:

2013

Language:

english

File:

PDF, 291 KB

english, 2013

20

I-017 Erythropoiesis stimulating agents in MDS

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 80 KB

english, 2013

21

Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome

Jadersten, M., Malcovati, L., Dybedal, I., Giovanni Della Porta, M., Invernizzi, R., Montgomery, S. M., Pascutto, C., Porwit, A., Cazzola, M., Hellstrom-Lindberg, E.

Journal:

Journal of Clinical Oncology

Year:

2008

Language:

english

File:

PDF, 142 KB

english, 2008

22

Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes

Gerstung, Moritz, Pellagatti, Andrea, Malcovati, Luca, Giagounidis, Aristoteles, Porta, Matteo G Della, Jädersten, Martin, Dolatshad, Hamid, Verma, Amit, Cross, Nicholas C. P., Vyas, Paresh, Killick,

Journal:

Nature Communications

Year:

2015

Language:

english

File:

PDF, 1.64 MB

english, 2015

23

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

Pellagatti, A., Jadersten, M., Forsblom, A.-M., Cattan, H., Christensson, B., Emanuelsson, E. K., Merup, M., Nilsson, L., Samuelsson, J., Sander, B., Wainscoat, J. S., Boultwood, J., Hellstrom-Lindber

Journal:

Proceedings of the National Academy of Sciences

Year:

2007

Language:

english

File:

PDF, 1.00 MB

english, 2007

24

TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

Jadersten, M., Saft, L., Smith, A., Kulasekararaj, A., Pomplun, S., Gohring, G., Hedlund, A., Hast, R., Schlegelberger, B., Porwit, A., Hellstrom-Lindberg, E., Mufti, G. J.

Journal:

Journal of Clinical Oncology

Year:

2011

Language:

english

File:

PDF, 747 KB

english, 2011

25

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

Koreth, J., Pidala, J., Perez, W. S., Deeg, H. J., Garcia-Manero, G., Malcovati, L., Cazzola, M., Park, S., Itzykson, R., Ades, L., Fenaux, P., Jadersten, M., Hellstrom-Lindberg, E., Gale, R. P., Beac

Journal:

Journal of Clinical Oncology

Year:

2013

Language:

english

File:

PDF, 188 KB

english, 2013

26

307 DEVELOPMENT AND IMPLEMENTATION OF A NEW BIOBANK SYSTEM

Jansson, M., Walldin, G., Azenkoud, A. Ben, Dimitriou, M., Karimi, M., Tobiasson, M., Jädersten, M., Tapia, J., Lindberg, E. Hellström

Journal:

Leukemia Research

Year:

2015

Language:

english

File:

PDF, 111 KB

english, 2015

27

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

Malcovati, L., Karimi, M., Papaemmanuil, E., Ambaglio, I., Jadersten, M., Jansson, M., Elena, C., Galli, A., Walldin, G., Della Porta, M. G., Raaschou-Jensen, K., Travaglino, E., Kallenbach, K., Pietr

Journal:

Year:

2015

Language:

english

File:

PDF, 1.13 MB

english, 2015

28

Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion

Journal:

Year:

2010

Language:

english

File:

PDF, 1.54 MB

english, 2010

29

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations

Scharenberg, Christian, Giai, Valentina, Pellagatti, Andrea, Saft, Leonie, Dimitriou, Marios, Jansson, Monika, Jädersten, Martin, Grandien, Alf, Douagi, Iyadh, Neuberg, Donna S., LeBlanc, Katarina, Bo

Journal:

Year:

2017

Language:

english

File:

PDF, 6.27 MB

english, 2017

30

Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities

Mollgard, L., Saft, L., Treppendahl, M. B., Dybedal, I., Norgaard, J. M., Astermark, J., Ejerblad, E., Garelius, H., Dufva, I. H., Jansson, M., Jadersten, M., Kjeldsen, L., Linder, O., Nilsson, L., Ve

Journal:

Year:

2011

Language:

english

File:

PDF, 692 KB

english, 2011

31

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression

Jadersten, M., Saft, L., Pellagatti, A., Gohring, G., Wainscoat, J. S., Boultwood, J., Porwit, A., Schlegelberger, B., Hellstrom-Lindberg, E.

Journal:

Year:

2009

Language:

english

File:

PDF, 297 KB

english, 2009

32

Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring

Jadersten, M., Karsan, A.

Journal:

Year:

2011

Language:

english

File:

PDF, 1.10 MB

english, 2011

33

PCR with electrospray ionization-mass spectrometry on bronchoalveolar lavage for detection of invasive mold infections in hematological patients

Krifors, Anders, Özenci, Volkan, Ullberg, Måns, Ackefors, Malin, Jädersten, Martin, Strålin, Kristoffer, Blennow, Ola, Chaturvedi, Vishnu

Journal:

Year:

2019

Language:

english

File:

PDF, 1.19 MB

english, 2019

34

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

Juliusson, Gunnar, Hagberg, Oskar, Lazarevic, Vladimir Lj, Ölander, Emma, Antunovic, Petar, Cammenga, Jörg, Wennström, Lovisa, Möllgård, Lars, Brune, Mats, Jädersten, Martin, Deneberg, Stefan, Lehmann

Journal:

Year:

2019

Language:

english

File:

PDF, 1.27 MB

english, 2019